Nascent polypeptide-associated complex a (aNAC) is reportedly overexpressed in several types of cancers and regulates cell apoptosis under hypoxic conditions in HeLa cells. The aim of our study was to investigate the apoptotic function of aNAC in cancer progression. First, we observed the cellular effects of aNAC depletion. Mouse aNAC was used to restore the protein level and verify the effect. An Annexin V assay, a caspase activity reporter assay, an apoptotic molecular marker, and a colony formation assay were used as markers to investigate the mechanisms of cell death caused by aNAC depletion. The Cancer 10-pathway reporter assay was used to screen downstream pathways. PCR site-directed deletion based on the functional domains of aNAC was used to construct deletion mutants. Those functional domain deletion mutants were used to recover the apoptotic phenotype caused by aNAC depletion. Finally, the role of aNAC in TNF-related apoptosis-inducing ligand (TRAIL) treatment was investigated in vitro. We found that depletion of aNAC in multiple types of cancer cells induce typical apoptotic cell death. This anti-apoptotic function is mediated by the FADD/c-Jun N-terminal kinase pathway. Intact aNAC is required for the direct binding of FADD as well as its anti-apoptosis function. Either aNAC depletion or the deletion of the ubiquitin-associated domain of aNAC sensitizes L929 cancer cells to mTRAIL treatment. Our study revealed a aNAC anti-apoptotic function in multiple types of cancer cells and suggested its potential in cancer therapy.
Following the interaction of DRs with cell death ligands and FADD, two cell death pathways are initiated by two different protein groups. The first group includes CD95/Fas, DR4/ TRAIL-R1, and DR5/TRAIL-R2, all of which recruit the death-inducing signaling complex composed of FADD and procaspase-8. 4 Death-inducing signaling complex facilitates auto-proteolytic cleavage of procaspase-8 and -10, which confers enzymatic activity on the proteins and allows their release. 3 Activation of caspase-8 and -10 leads to proteolytic stimulation of the downstream effectors caspase-3, -6, and -7, which can cleave intracellular substrates, such as lamin A, poly-(ADP-ribose) polymerase (PARP), and MEKK1. 4, 5 The second group of DRs, including TNFR1, DR3, DR6, and EDAR, recruit TRADD as an adaptor protein that links DRs to TNF receptor-associated factors 2,5, receptor-interacting protein kinase (RIP1 or RIPK1), and cellular inhibitor of apoptosis, forming two signaling complexes called 'complex I' and 'complex II,' both of which can initiate apoptosis. 2, [6] [7] [8] JNK (c-Jun N-terminal kinases) pathway activation has been reported to mediate DR-induced apoptosis in multiple types of cell lines. [9] [10] [11] [12] [13] DR/FADD activates JNK by two different pathways. Activated caspase is able to cleave MEKK1 and enhance its kinase activity, further inducing JNK activation via the MAPK (mitogen-activated protein kinases) cascade. 5 DR/FADD is also responsible for the recruitment and activation of the kinase ASK1. ASK1 in turn activates the MAPK cascade, resulting in JNK activation.
eukaryotes as a ribosome-associated factor in close proximity to nascent chains. 20, 21 NAC containing a and b subunits interacts with unfolded polypeptide chains independent of their amino-acid sequence. 21 Recent studies indicate that aNAC has b-subunit-independent functions in development, 22 transcriptional factor regulation, 23 endoplasmic reticulum stress, and apoptosis. 24 Clinical studies have observed elevated aNAC protein levels in multiple types of cancers, such as malignant gliomas, 25 breast adenocarcinoma, 26 and juvenile myelomonocytic leukemia. 27 The functional mechanism of aNAC in cancer progression remains largely unknown. A previous study reported that aNAC interacts with FADD. 28 In the present study, aNAC was documented to exhibit an anti-apoptotic function in different cancer cell lines. Furthermore, we demonstrated that the FADD/JNK pathway is the downstream pathway of aNAC and that aNAC is required for oncogenic transformation in normal fibroblast cells.
Results
Depletion of aNAC decreases cancer cell viability. We generated shRNAs to deplete aNAC ( Figure 1a ) in several cancer cell lines, including PC3 (prostate), H1299 (lung), MCF7 (breast), HCT116 (colon), and Hela (cervix; Figure 1b , Supplementary Figure 1) . Surprisingly, aNAC was able to decrease cell viability by over 75% in all cancer cell lines except Hela cells (Figure 3a) . To avoid the off-target effect of shRNA, we rescued aNAC protein levels in aNAC-depleted PC3 cells using mouse aNAC (maNAC; Figure 1c) . maNAC, which exhibits 99% identity with human aNAC (Supplementary Figure 2) , was able to recover over 60% of cell viability (Figure 1d ). Cell growth curve analyses were performed. aNAC-depleted cells grew slower than control cells, whereas the introduction of exogenous maNAC into aNAC-depleted cells was able to rescue the growth defect (Figure 1e ).
Depletion of aNAC induces caspase-8-dependent apoptosis.
To pursue the mechanism of aNAC depletion-mediated cell viability inhibition, Annexin V assays were performed. Less than 5% of control PC3 cells exhibited Annexin V-positive signals, whereas approximately 90% of aNAC-depleted cells exhibited Annexin V-positive signals (Figure 2a) . To verify the results of the Annexin V assay, several apoptotic molecular markers were investigated. The levels of caspase-3, -8, and -9 cleavage were much higher in aNACdepleted PC3 cells compared with the control. PARP, which is a substrate of caspases, was cleaved more frequently in aNAC-depleted cells than in control cells (Figure 2b ). Caspase-3 receives signals from caspase-8 or -9 in response to the extrinsic apoptotic pathway or the intrinsic apoptotic pathway, respectively. Thus, we introduced dominant-negative caspase-3, -8, or -9 into control or aNACdepleted cells and observed caspase-3 activity. In PC3 cells transfected with control empty vector, caspase-3 activity increased twofold. In caspase-3 DN-and caspase-8 DNtransfected cells, caspase-3 activity was inhibited. Interestingly, caspase-9 DN was not able to inhibit caspase-3 activity efficiently (Figure 2c ). This result suggests that the apoptotic process was initiated by the extrinsic pathway when aNAC was depleted.
FADD mediates apoptosis under aNAC-depleted conditions. Among the cancer cells we detected, HeLa cells exhibited a much lower cell death response under aNAC depletion compared with the other cells we measured. Over 50% of HeLa cells survived aNAC depletion (Figure 3a) . HeLa cells harbors human papillomavirus 18 virus, which express the E6 protein that is able to inhibit p53 29 and FADD 30 function and protect cells from apoptosis. PC3 and PC3-E6 cells were used to test the hypothesis that E6 was responsible for HeLa cell resistance. Less than 5% of PC3 shaNAC cells survived, whereas over 80% of PC3-E6 shaNAC cells survived (Figure 3b ). aNAC depletion efficiently induced cell death in PC3 and H1299 cells, both of which cells are functional p53-null. Therefore, we further investigated the role of FADD role. When FADD was co-depleted with aNAC, approximately 80% of the cells survived (Figure 3c ). Caspase-3, -8, and -9 activities were measured in the indicated cells (Figure 3d ). The activities of all three caspases were enhanced only in aNAC-depleted cells and inhibited in FADD-depleted cells. PARP and caspase-3 cleavage were decreased in the 'shaNAC þ shFADD' group as well (Figure 3e ). The statistic analysis for p-JNK signal was done (Supplementary Figure 5) .
The MAPK/JNK pathway mediates the apoptotic effect of aNAC depletion. To investigate the signal transduction under aNAC depletion conditions, Cancer 10-pathway assays were performed. The activity of two pathways, MAPK/ERK and MAPK/JNK, increased over twofold. In particular, the JNK pathway increased over fivefold (Figure 4a ). To block MEKK and JNK activity, two dominant-negative kinase-dead proteins, MEKK-CF-KR and JNK-APF, were introduced into aNAC-depleted or control PC3 cells. Both kinase-dead proteins were able to inhibit JNK phosphorylation and caspase-3 cleavage, and JNK-APF was more potent than MEKK-CF-KR (Figure 4b ). The statistic analysis for p-JNK signal was done (Supplementary Figure 6) . Colony formation experiments revealed that both kinase-dead proteins were able to rescue the cell viability that was decreased by aNAC depletion and that JNK-APF was more potent than MEKK-CF-KR ( Figure 4c ). Pathway activities were measured using a transcriptional luciferase reporter assay. JNK-APF was able to inhibit AP1 transcriptional activity over 70%. MEKK-CF-KR was able to inhibit SRE transcriptional activity over 50% (Supplementary Figure 3) . Depletion of maNAC or the addition of the D185-215 mutant sensitized the murine aneuploid fibrosarcoma cell line L929 to mTRAIL treatment. TRAIL has been used clinically for tumor therapy purposes to induce extrinsic apoptotic cell death. We used L929 cells, which are sensitive to mTRAIL treatment in vitro, as a model. mTRAIL alone induced 45% cell death. The combination of mTRAIL with the D185-215 mutant or shNAC induced more cell death. Interestingly, the D180-215 mutant only induced approximately 40% cell death, whereas 85% cell death was observed when the mutant was combined with mTRAIL treatment (Figures 7a and b) .
Discussion
The extrinsic apoptotic pathway has a very important role in cancer progression as well as in cancer therapy. Malignant cells develop several strategies to inhibit the extrinsic apoptotic pathway activity against death signals, such as TNFa, TRAIL, and Fas ligand. Downregulation of DRs is often aNAC regulates apoptosis via the FADD-JNK axis W Zeng et al Figure 5 Intact aNAC is required for anti-apoptotic function. (a) The strategy for creating the aNAC deletion mutant. All mutants were introduced into PC3 cells to make stable cells, and the cells were then infected with shGFP or shaNAC lentiviruses. All cells were subjected to colony formation assays and counted the colony numbers (b), JNK pathway reporter assays (c), and western blot analysis (d) Figure 6 Identification of the interaction domain of aNAC and FADD. (a) Approximately 2 Â 10 7 cells were harvested, lysed in RIPA buffer, and separated into three parts. Approximately 5% lysate was used as an 'input' sample, half of the remaining lysate was incubated with normal rabbit IgG, which was severed as negative control, and the other half of the remaining lysate was incubated with FADD antibody. After overnight incubation at 4 1C, the samples were washed three times with PBS and then subjected to western blot analysis. (b) The Endogenous aNAC and FADD distribution were investigated by IF. (c) Full-length GFP-tagged FADD was co-transfected with full-length maNAC or deletion mutants. IP was performed with M2 beads to precipitate flag-tagged maNAC. Co-precipitated FADD was probed using an anti-FADD antibody. An un-related protein, YB1, served as a negative control. (d) Full-length flag-tagged maNAC was co-transfected with full-length GFP-tagged FADD or deletion mutants. IP was performed to pull down M2 beads to precipitate flag-tagged maNAC. Co-precipitated FADD was probed using an anti-FADD antibody. An un-related protein, Rab7, served as a negative control aNAC regulates apoptosis via the FADD-JNK axis W Zeng et al associated with resistance to drug-induced cell death. [31] [32] [33] Downregulation of Fas signaling can be attributed to changes at the genomic, transcriptional, and posttranslational levels. Mutations in the death domain of Fas have been reported in 7% of metastatic melanomas, 34 resulting in an abnormal protein that exhibits abrogated associations with FADD and procaspase-8. A more common event is silencing of the Fas receptor promoter. [35] [36] [37] Another means of attenuating Fas expression is its selective inhibition from being expressed on the cell surface. 38, 39 All of those pathological changes are able to attenuate signal transduction and cellular responses to death signals. Recent studies have revealed that targeting several downstream proteins, such as cellular FLICE-like inhibitory protein 40, 41 and caspase-8, 42 is able to overcome the drug resistance caused by the downregulation of DRs. Our study provides evidence that the depletion of aNAC potently induces apoptotic cell death in multiple cancer cell lines but not in normal fibroblast cells. aNAC is a potential candidate for cancer therapy.
aNAC harbors a UBA domain in its extreme C-terminus. The UBA domain is a small structural domain in proteins that is characterized by a three-helix bundle and is typically associated with the ubiquitin pathway. Binding of the long-chain ubiquitin of the proteins to UBA proteins is able to promote their degradation. 43 Some proteins harboring UBA domains have been identified in the ubiquitin-associated proteasome pathway, such as nuclear factor-kB essential modulator, R23A, Dsk2, and NBR1. [44] [45] [46] [47] All of these proteins belong to class 1, 2, or 4 UBAs. Class 3, to which aNAC belongs, exhibits no demonstrable binding affinity with longchain ubiquitin in yeast (Egd2 is homologue of aNAC in yeast). We do not find any evidence to support that aNAC regulates FADD by regulating protein stability because the depletion or overexpression of aNAC did not significantly change the FADD level. Therefore, it would be interesting to investigate the binding affinity between FADD and caspase-8 or RIP1 with or without aNAC.
Interestingly, the D180-215 mutant, deleted with UBA domain, activates AP1 pathway and inhibits cell viability when overexpressed in PC3 cells only. D180-215 mutant also sensitized mTRAIL-induced L929 cell apoptosis in vitro. Considering those effect is consistent with aNAC depletion, we propose UBA domain has an important role in aNAC antiapoptotic function. Further investigation focusing on this domain would be helpful to clarify the mechanism.
Depletion of FADD completely blocked JNK phosphorylation (Figure 3e ), suggesting that JNK activation is the downstream of FADD. Depletion of FADD efficiently recovers cell apoptosis induced by aNAC depletion. Overexpression of JNK APF in aNAC-depleted cells was able to recover cell viability to 40% (Figure 4c) , although it blocked endogenous JNK activity over 70% (Supplementary Figure 3) . Therefore, the JNK pathway is the major but not the only pathway to mediate the aNAC/FADD effect. The signal transduction from FADD to JNK has two potential pathways, correspondingly mediated by MEKK1 4 or ASK. 14 When endogenous MEKK1 was inhibited by MEKK-CF-KR, cell viability decreased to approximately 20%. Thus, MEKK1 is not the only mediator of signal transduction from FADD to JNK (Supplementary Figure 5) .
Caspases response to apoptotic signal by two ways. For a short-time stimulation, caspases were cleaved and activated. For sustained stress, JNK and other pathways promote caspase gene transcription and elevate those protein levels. 48 In this study, we used lentivirus to introduce siRNA against aNAC into cells. It takes about 3 days. We found not only caspase cleavage but also caspase protein level elevation in aNAC-depleted cells. It is consistent with the JNK activation we found.
When cell undergo extrinsic apoptosis, in so-called type 1 cells, proteolytic activation of caspases-3 by caspase-8 suffices for efficient apoptosis induction. In so-called type 2 cells, killing requires amplification of the caspase cascade. This can be achieved through caspase-8-mediated proteolytic activation of the pro-apoptotic Bcl-2 homology domain (BH) 3-only protein BH3-interacting domain death agonist (Bid), which then causes mitochondrial outer membrane permeabilization. 49 Further investigation is required to clarify BID's role when aNAC was depleted.
Our study revealed that aNAC, a nascent peptide-associated protein, exhibits an anti-apoptotic function independent of the NAC complex in cancer cells. The anti-apoptotic mechanism of aNAC was concluded as a diagram Figure 8 ). aNAC is a potential therapy target, and further study on the mechanism of aNAC regulation of FADD is necessary. were purchased from Addgene (http://www.addgene.org) and were sub-cloned into corresponding lentiviral expression plasmids. All the details of those plasmids are available in the references correspondingly. PCRs were performed with KOD Taq polymerase (TOYOBO, Novi, MI, USA) and Mastercycler nexus (Eppendorf, Hamburg, Germany).
Cell culture, transfection, and reagents. PC3, MCF7, H1299, MDA-MB-231, U2OS, and 293T cells were purchased from the American Type Culture Collection and were maintained in their corresponding media as standard protocol. PC3-E6 cells were created and maintained following the published MCF7-E6 building methods. 56 All cell culture reagents were purchased from Gibco (New York, NY, USA). Mouse TRAIL (Cat. SRP3237) and other reagents were purchased from Sigma (St. Louis, MO, USA) unless otherwise indicated. Transfections were performed with Lipofectamine 2000 (Invitrogen) according to the standard instructions. In each experiment, the amounts of the transfected plasmids were consistent, and an empty vector was used to compensate for any remaining amount. Each experiment was repeated three times.
Cancer 10-pathway reporter arrays. The Cancer 10-pathway Reporter kit (CCA-001L) was purchased from SABiosciences (Frederick, MA, USA). The screening process was performed following the standard manual. In brief, MCF7 cells were seeded into 96-well plates at a density of 1 Â 10 4 cells per well. Reverse transfections were performed when the cells were seeded. After 48 h, the cells were harvested and subjected to dual luciferase analysis, which was performed using the Dual-Luciferase Reporter Assay System (E1960, Promega, Madison, WI, USA). Cruz Biotechnology (Dallas, TX, USA). Flag (F4042, 1:5000, mouse), Flag (F2555, 1:1000, rabbit), and actin (A4700, 1:5000) antibodies and Anti-FLAG M2 Magnetic Beads (M8823) were purchased from Sigma. PARP (9532, 1:500), cleaved caspase-3 (9664, 1:500), cleaved caspase-8 (9496, 1:500), cleaved caspase-9 (9505, 1:500), and p-JNK (4668, 1:1000) antibodies were purchased from Cell Signaling Technology (Danvers, MA, USA). The goat anti-mouse (SC-2005, 1:500) and goat anti-rabbit (SC-2004, 1:500) secondary antibodies were purchased from Santa Cruz Biotechnology. The secondary antibodies used for IF were purchased from Invitrogen, including Alexa Fluor 594 (A11020, 1:500) and Alexa Fluor 488 (A11034, 1:500). The blot images were taken using a ChemiDoc XRS þ system (Bio-Rad, Hercules, CA, USA). IF images were taken by microscopy (CX41-32RFL, OLYMPUS). IP was performed following a previous protocol. 52 Virus packaging and infection. The pLKO1 plasmid, pLenti entrydestination system, 57 and helper vectors, VSVG and delta8.2, were purchased from Addgene. Virus packaging and target cell infection were performed following standard protocols from Addgene. Stable cell lines were created by selection with 1 mg/ml puromycin (P9620, Sigma) for 6 days.
Annexin V assay. The Annexin V-FITC Apoptosis Detection Kit was purchased from Sigma (APOAF-50TST). Cells were seeded on sterile cover slides in 35 mm dishes. The following day, cells were washed with PBS twice and incubated with the Annexin V-FITC working solution for 30 min. Slides were placed cell-side down on slides, and positively stained cells were counted under a microscope.
Caspase enzyme activity assay. Three caspase activity assay kits, caspase-Glo3/7 (G8090), caspase-Glo8 (G8200), and caspase-Glo9 (G8210), were purchased from Promega. Experiments were performed according to the manufacturer's manual.
Colony formation assay. Cells were trypsinized and suspended in culture medium. After counting, cells were diluted to 50 cells/ml. Approximately 2 ml of cell suspension (approximately 100 cells) was seeded into each 60 mm dish. The medium was changed every 1 or 2 days. After 2 weeks under normal conditions, cells were fixed in 4% formaldehyde for 10 min. After two washes with PBS, 0.05% crystal violet was added to the dishes. After 15 min, crystal violet was removed, and the cells were washed twice with PBS (upper panel). Colonies were counted using ImageJ software (version 1.43; http://rsbweb.nih.gov/ij/download.html).
Statistical analysis and software. All experiments were repeated three times. For each histogram, the average value and error bar were calculated from three independent experiments. GraphPad Prism 5 was used to analyze the data and create histograms. One-way ANOVA was used to assess statistical significance for certain data. A double asterisk (**) indicates Po0.01, and a single asterisk (*) indicates Po0.05.
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